As of Sep 19
| +0.10 / +2.30%|
The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.25, with a high estimate of 10.00 and a low estimate of 5.50. The median estimate represents a +40.45% increase from the last price of 4.45.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.